CNS postdoctoral researcher Alper Sinan Akyurek and CSE professor Tajana Rosing developed an algorithm for controlling batteries that can decrease the utility cost of an actual building by up to 50 percent compared to a building powered without the use of batteries.
An international team of scientists, led by researchers at University of California San Diego School of Medicine and University of California San Francisco, has developed a novel genetic score that allows individuals to calculate their age-specific risk of developing Alzheimer’s disease (AD), based upon genetic information.
Graduate students at the University of California San Diego will stage an original work and performance on Thursday, March 23, in the Qualcomm Institute on the university campus. Their interdisciplinary work, “The Burden of Selfhood”, will explore the themes of feminism, identity and technology.
Standard antidepressant medications don’t work for everyone, and even when they do they are slow to kick in. In an effort to find better depression treatments, researchers at University of California San Diego School of Medicine discovered that inhibiting an enzyme called Glyoxalase 1 (GLO1) relieves signs of depression in mice. Moreover, inhibiting GLO1 worked much faster than the conventional antidepressant Prozac.
Faced with a downturn in visitors, the San Diego History Center (SDHC) decided to take an innovative approach to boosting museum attendance – let visitors determine how much they wanted to pay for their visit. The museum’s “Give Forward” admissions program launched in October 2016 and, to date, has given it a significant boost in attendance. This fundamental shift in admissions was inspired by the research of Ayelet Gneezy and Uri Gneezy, faculty at the Rady School of Management at UC San Diego, and experts in charitable giving. Working with the Rady School professors, the museum determined the best way to increase admissions was to allow visitors to contribute based on their experience in the museum, instead of paying a set admissions fee. In addition, the museum highlights to visitors that admissions donations help pay for other people to visit in the future.
Genetic mutations that cause cancer also weaken cancer cells, allowing researchers to develop drugs that will selectively kill them. This is called “synthetic lethality” because the drug is only lethal to mutated (synthetic) cells. Researchers at UC San Diego School of Medicine and Jacobs School of Engineering developed a method to search for synthetic-lethal gene combinations. The technique, published March 20 in Nature Methods, uncovered 120 new opportunities for cancer drug development.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
